Approvals/CIMA-AEMPS/BREYANZI 1,1-70 × 10E6 CELULAS/ML / 1,1-70 × 10E6 CELULAS/ML DISPERSION PARA PERFUSION

Approved

STANDARD

BREYANZI 1,1-70 × 10E6 CELULAS/ML / 1,1-70 × 10E6 CELULAS/ML DISPERSION PARA PERFUSION

Bristol-Myers Squibb Pharma Eeig🇪🇸 Spanish Agency of Medicines and Medical Devices

Approval Id: 2497ce416a73f7ea
Drug Cima Aemps Name: BREYANZI 1,1-70 × 10E6 CELULAS/ML / 1,1-70 × 10E6 CELULAS/ML DISPERSION PARA PERFUSION
Register Number: 1221631001
Holder Company Name: Bristol-Myers Squibb Pharma Eeig
Marketing Company Name: Bristol Myers Squibb S.A.
Holder Company Detail Path: /organization/bristol-myers-squibb-pharma-eeig
Authorization Date: 2025-05-08
Dosage Form: DISPERSION PARA PERFUSION
Dose: 1,1-70x10e6/1,1-70x10e6 celulas/ml
Route Of Administration: VÍA INTRAVENOSA
Prescription Type: Uso Hospitalario
Commercialized: No
Company Name: Bristol-Myers Squibb Pharma Eeig
Company Detail Path: /organization/bristol-myers-squibb-pharma-eeig

LISOCABTAGEN MARALEUCEL

1,1-70 × 10e6 CELULAS

Approved

Agency

CIMA-AEMPS

Country

🇪🇸

Approval Date

May 8, 2025

Approval ID

2497ce416a73f7ea

Type

Standard